Ethylmalonic encephalopathy

A rare genetic disorder affecting metabolism

Ethylmalonic encephalopathy is a rare genetic disorder that primarily affects the nervous system, gastrointestinal tract, and blood vessels. It is characterized by a combination of neurological symptoms, chronic diarrhea, and vascular lesions. The condition is caused by mutations in the ETHE1 gene, which plays a crucial role in the metabolism of sulfur-containing compounds.

Signs and symptoms

Individuals with ethylmalonic encephalopathy typically present with symptoms in infancy or early childhood. Common signs and symptoms include:

• Neurological symptoms: These may include developmental delay, hypotonia (reduced muscle tone), seizures, and ataxia (lack of voluntary coordination of muscle movements).
• Gastrointestinal symptoms: Chronic diarrhea is a hallmark of the condition, often leading to dehydration and malnutrition.
• Vascular lesions: Patients may develop petechiae (small red or purple spots on the skin) and other vascular abnormalities due to small blood vessel damage.
• Metabolic abnormalities: Elevated levels of ethylmalonic acid and other metabolites can be detected in the urine.

Genetics

Ethylmalonic encephalopathy is inherited in an autosomal recessive pattern, meaning that both copies of the ETHE1 gene in each cell have mutations. The ETHE1 gene provides instructions for making an enzyme that is involved in the breakdown of sulfur-containing compounds. Mutations in this gene lead to the accumulation of toxic substances that damage cells and tissues, particularly in the brain and blood vessels.

Diagnosis

Diagnosis of ethylmalonic encephalopathy is based on clinical evaluation, laboratory tests, and genetic testing. Key diagnostic indicators include:

• Biochemical testing: Elevated levels of ethylmalonic acid in the urine are a significant marker.
• Genetic testing: Identification of mutations in the ETHE1 gene confirms the diagnosis.
• Imaging studies: Magnetic resonance imaging (MRI) of the brain may reveal characteristic changes associated with the disorder.

Treatment

There is currently no cure for ethylmalonic encephalopathy, and treatment is primarily supportive and symptomatic. Management strategies may include:

• Nutritional support: Addressing malnutrition and dehydration due to chronic diarrhea.
• Seizure management: Use of anticonvulsant medications to control seizures.
• Physical therapy: To improve muscle tone and coordination.
• Experimental therapies: Research is ongoing to explore potential treatments that target the underlying metabolic defect.

Prognosis

The prognosis for individuals with ethylmalonic encephalopathy varies. The condition is progressive, and the severity of symptoms can differ among affected individuals. Early diagnosis and intervention may improve quality of life and outcomes.

Related pages

• Genetic disorder
• Metabolic disorder
• Neurological disorder
• Autosomal recessive inheritance